Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | LMNA | P02545 | 3/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.30 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26415659 | 0.96 | L3MBTL1 (0.36) | L3MBTL1CYP1A2KDM4EALDH1A1LMNA | |
| SCHEMBL26416719 | 0.95 | L3MBTL1 (0.36) | L3MBTL1CYP1A2KDM4EALDH1A1LMNA | |
| SCHEMBL26416716 | 0.92 | L3MBTL1 (0.38) | L3MBTL1CYP1A2KDM4EALDH1A1LMNA | |
| SCHEMBL26415506 | 0.90 | L3MBTL1 (0.32) | L3MBTL1 | |
| SCHEMBL26415667 | 0.89 | PSMB5 (0.34) | L3MBTL1KDM4EALDH1A1LMNAGAA | |
| SCHEMBL26415656 | 0.87 | CYP1A2 (0.32) | L3MBTL1CYP1A2GAAPIK3R1PIK3CA | |
| SCHEMBL26415697 | 0.87 | L3MBTL1 (0.34) | L3MBTL1KDM4EALDH1A1LMNAGAA | |
| SCHEMBL26415503 | 0.85 | L3MBTL1 (0.33) | L3MBTL1KDM4EALDH1A1LMNAGAA | |
| SCHEMBL25057649 | 0.85 | L3MBTL1 (0.34) | L3MBTL1CYP1A2KDM4EALDH1A1LMNA | |
| SCHEMBL26415530 | 0.85 | PLA2G2A (0.31) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230128360-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE | LT MATERIALS CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230128360-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE | CRY1, ORC3, ODC1 | L3MBTL1 2788/4885CYP1A2 15/4885KDM4E 3080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.